This systematic comparison of ctDNA vs tissue sequencing by Ryan Corcoran Gad Getz & cols. shows the superiority of liquid biopsy for capturing clinically relevant alterations mediating therapy resistance in Cancer patients httpswww.nature.comartic

This systematic comparison of ctDNA vs tissue sequencing by Ryan Corcoran, Gad Getz & cols. shows the superiority of liquid biopsy for capturing clinically relevant alterations mediating therapy resistance in #Cancer patients https://www.nature.com/artic

10:31 EDT 10 Sep 2019 | Nature Publishing

This systematic comparison of ctDNA vs tissue sequencing by Ryan Corcoran, Gad Getz & cols. shows the superiority of liquid biopsy for capturing clinically relevant alterations mediating therapy resistance in #Cancer patients https://www.nature.com/articles/s41591-019-0561-9 … #PrecisionMedicine #Genomics pic.twitter.com/cpH2TPrx8m

More From BioPortfolio on "This systematic comparison of ctDNA vs tissue sequencing by Ryan Corcoran, Gad Getz & cols. shows the superiority of liquid biopsy for capturing clinically relevant alterations mediating therapy resistance in #Cancer patients https://www.nature.com/artic"